Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05690178
Other study ID # DTM-CLBP-OW
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date October 20, 2021

Study information

Verified date August 2023
Source Poznan University of Physical Education
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of the study was to assess the impact of deep tissue massage on subjective and objective parameters in a group of office workers with chronic low back pain. Specific objectives: - Assessment of the impact of deep tissue massage on the level of pain - Assessment of the impact of deep tissue massage on the level of disability - Assessment of the impact of deep tissue massage on the mobility of the lumbar spine - Assessment of the effect of deep tissue massage on the discomfort threshold of tissue compression in the area of the erector spinae muscle - Assessment of the impact of deep tissue massage on the biophysical parameters of the soft tissues of the erector spinae muscle - Evaluation of the impact of deep tissue massage on the bioelectric potentials of the erector spinae muscle during everyday activities and the flexion-relaxation test Hypotheses: - Deep tissue massage will reduce the level of pain in the lumbar spine - Deep tissue massage will reduce the level of disability - Deep tissue massage will increase the range of motion of the lumbar spine in all directions - Deep tissue massage will reduce the threshold of discomfort when compressing the soft tissues of the erector spinae muscle - Deep tissue massage will reduce muscle tone and stiffness and increase the elasticity of the back extensor muscle - Deep tissue massage will increase the bioelectrical potentials of the erector spinae muscle while performing tests of activities of daily living - Deep tissue massage will reduce the value of the flexion-relaxation test


Description:

Deep tissue massage is a manual action of the therapist in the superficial and deep layers of muscles and fascia in order to relax, change abnormal patterns, eliminate tension and pain in a maximally ergonomic way. Deep tissue massage should be described as an independent method of therapy using a specific set of techniques and principles. It is a safe method with a wide range of applications, while the techniques themselves can be modified to the needs of the patient. It is believed that deep tissue massage causes: improvement of tissue blood supply, reduction of muscle tension, stretching of muscles and fascia, improvement of muscle and joint function. Participants A total of 40 patients (30 to 60 years of age) participated in the study. All participants were characterized by the presence of chronic low back pain syndrome, performed office work for 8 hours a day and were characterized by moderate physical activity. Using randomization, participants were divided into two groups (experimental and control). The experimental group included participants who received deep tissue massage (N=20, 18 women and 2 men, average age: 40). The control group included participants who did not receive therapy (N=20, 13 women and 7 men, average age: 43). Intervention The deep tissue massage lasted 45 minutes. The entire therapy included 4 treatments over a period of 2 weeks. The interval between treatments was 3 days. The conducted therapy included techniques for: quadratus lumborum muscle, erector spinae muscle, thoracolumbar fascia, iliopsoas muscle. All techniques were performed on both sides of the patient's body. Research methods The following measurement equipment was used to collect the data: 1. Electrogoniometer. Penny & Giles strain gauge electrogoniometer with two sensors (SG150 - two-axis, Q110 - single-axis). Measurements were taken in a standing position, in accordance with the measurement methodology according to Lewandowsky. All movements of the lumbar spine (forward bending, backward bending, right bending, left bending, right rotation, left rotation) were examined. The average of the three measurements was the result of movability for a given direction. The sensors were attached to the skin using Biometrics double-sided tape. The upper sensor was placed on the Th12 spinous process (lower edge of the sensor), while the lower sensor was mounted on the base of the sacrum (upper edge). 2. Algometer. The Wagner Instruments algometer was used to assess the subjective parameter, i.e. the first discomfort threshold. In the study, the measurement site was the point located on the longissimus muscle, which is a component of the erector spinae muscle. The subjects lay in front. The pressure, detected by the algometer sensor, was applied from above and perpendicularly to the examined muscle (two fingers laterally from the L1 spinous process). Three measurements were made alternately for both sides of the examined muscle. From these measurements, mean values were calculated, which were the results for the right and left sides of the examined muscle. 3. MyotonPRO. In order to study the biophysical parameters of soft tissues, i.e. muscle tone (F) [Hz], stiffness (S) [N/m] and elasticity (D) [no units], the MyotonPRO apparatus was used. During the measurements, the tested person lay on his front. Measurements were made on the longissimus muscle (2 fingers lateral to the L1 spinous process). The pattern composer was programmed as follows: tapping time: 15 ms, interval: 0.8 s, mode: multiscan (5 repetitions). Measurements were made on the right and left muscles. 4. Kinesiologic electromyography (EMG). Kinesiologic electromyography was carried out with an 8-channel electromyographic system with plate electrodes (model W4X8, Biometrics Ltd). The results were recorded using DataLog Bluetooth V7.5 software (Biometrics Ltd). During the examination, six multiple-use surface electrodes (type SX230 1000) were attached with an adhesive tape, after removal of body hair froma 2 cm x 1 cm area of intact skin, disinfection of electrode surface, and wiping the skin a few times with salicylic alcohol to reduce its resistance. The reference electrode (type R230, Biometrics Ltd) was fixed at the distal end of the radius (Lister's tubercle region) with an elastic band. The examination involved lumbar segment of the longissimus muscle, iliocostalis and multifidus (both right- and left-sided bundles). The electrodes were placed according to the international guidelines published by SENIAM. The examination was painless and noninvasive and did not require subject's exposure to any additional electric stimulation. The measurement was preceded by a 10-min warm-up of the keymuscle groups. The list of determined electromyographic parameters included the amplitude of bioelectrical signal from the longissimus, iliocostalis and multifidus muscles, expressed in microvolt. Avoiding a confounding effect associated with measurement conditions, the results were normalized to a reference Maximum Voluntary Contraction (MVC) and expressed in percent. After fixation of the electrodes and preparation of the system, MVC of the longissimus, iliocostalis and multifidus were determined according to the international SENIAM guidelines. The examination started with the subject lying down in a prone position, with arms crossed under the chin, and extended legs. The EMG recordings were obtained during three active extensions of the spine, each lasting 3 seconds, with 30-second intervals in between. MVCs , corresponding to 100% neuromuscular activation of the muscles, was calculated as the mean amplitude for the three repetitions (for each muscle). At the beginning, the Flexion-Relaxation (FR) test was performed. The participant performed forward flexion of the spine and hung freely in this position for 10 seconds. During this test, the participant was asked to be as relaxed as possible. Then the participant was tested during successive tests of activities of daily living: getting up from a chair, sitting on it, lifting and lowering a 1 kg and 2 kg weight. Each test was run at an individually adjusted pace and consisted of three repetitions with 30-second rests between them. The test started at the investigator's request. While lifting and lowering the weights, the subjects kept a straight back, and each hold of the weight lasted 3 seconds and was performed on straight elbows. The result of each test is presented as the mean amplitude for three repetitions for each muscle. The results were normalized to the MVC to assess the degree of muscle involvement during various activities (standing up, sitting down, raising and lowering the roller) in relation to maximal neuromuscular activation. To ensure accurate results, the correct attachment of each electrode was rechecked before each repetition. 5. Revised Oswestry Pain Questionnaire (ODI). The degree of LBP imposed limitations in activity of daily ling (ADLs) was determined with Revised Oswestry Pain Questionnaire, also referred to as Oswestry Disability Index (ODI). The survey consisted of 10 questions, each with 6 possible responses scored from 0 to 5 points. If the respondent chose more than one answer to a given question, the one with higher score was recorded and subjected to the analysis. Maximum overall score amounted to 50 points, which corresponded to 100% disability due to lumbar pain. 6. Roland-Morris Disability Questionnaire (RMDQ). The instrument consists of 24 statements about pain and its influence on ADLs. The respondent chooses only the statements that refer to his/her ailments. Maximum overall score may vary between 0 and 24 points. 7. Visual-Analog Scale (VAS). This subjective tool is used to assess the level of pain. The participant marks the level of pain on a 10 cm scale, where 0 is no pain and 10 is the maximum pain he has ever felt. In order to assess the impact of deep tissue massage therapy on the study population, two measurements were made over time: before and after therapy. Ethics All measurement methods used were non-invasive and safe for health. The study was approved by the local Bioethics Committee. Each participant had the right to withdraw from the study at any stage. All collected data is anonymous and will be used only to conduct statistical analyzes for scientific purposes.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 20, 2021
Est. primary completion date October 20, 2021
Accepts healthy volunteers No
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - Chronic Low-Back Pain - office worker Exclusion Criteria: - spine surgeries - cauda equina syndrome - cancer - pain or motor and sensory deficits in the lower extremities below the level of the knee - various therapies to treat chronic low-back pain

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Deep Tissue Massage
The Deep Tissue Massage lasted 45 minutes. The entire therapy included 4 treatments over a period of 2 weeks. The interval between treatments was 3 days. The conducted therapy included techniques for: quadratus lumborum muscle, erector spinae muscle, thoracolumbar fascia, iliopsoas muscle. All techniques were performed on both sides of the patient's body.

Locations

Country Name City State
Poland Poznan University of Physical Education, Department of Biology and Anatomy Poznan Wielkopolska

Sponsors (1)

Lead Sponsor Collaborator
Poznan University of Physical Education

Country where clinical trial is conducted

Poland, 

References & Publications (23)

Bervoets DC, Luijsterburg PA, Alessie JJ, Buijs MJ, Verhagen AP. Massage therapy has short-term benefits for people with common musculoskeletal disorders compared to no treatment: a systematic review. J Physiother. 2015 Jul;61(3):106-16. doi: 10.1016/j.jp — View Citation

Best TM, Hunter R, Wilcox A, Haq F. Effectiveness of sports massage for recovery of skeletal muscle from strenuous exercise. Clin J Sport Med. 2008 Sep;18(5):446-60. doi: 10.1097/JSM.0b013e31818837a1. — View Citation

Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009 Dec 15;147(1-3):17-9. doi: 10.1016/j.pain.2009.08.020. Epub 2009 Sep 16. No abstract available. — View Citation

Cai XY, Sun MS, Huang YP, Liu ZX, Liu CJ, Du CF, Yang Q. Biomechanical Effect of L4 -L5 Intervertebral Disc Degeneration on the Lower Lumbar Spine: A Finite Element Study. Orthop Surg. 2020 Jun;12(3):917-930. doi: 10.1111/os.12703. Epub 2020 May 31. — View Citation

Furlan AD, Giraldo M, Baskwill A, Irvin E, Imamura M. Massage for low-back pain. Cochrane Database Syst Rev. 2015 Sep 1;2015(9):CD001929. doi: 10.1002/14651858.CD001929.pub3. — View Citation

Hansen AE, Marcus NJ. Is It Time to Consider Soft Tissue as a Pain Generator in Nonspecific Low Back Pain? Pain Med. 2016 Nov;17(11):1969-1970. doi: 10.1093/pm/pnw204. Epub 2016 Aug 27. No abstract available. — View Citation

Kassolik K, Andrzejewski W, Brzozowski M, Wilk I, Gorecka-Midura L, Ostrowska B, Krzyzanowski D, Kurpas D. Comparison of massage based on the tensegrity principle and classic massage in treating chronic shoulder pain. J Manipulative Physiol Ther. 2013 Sep — View Citation

Koren Y, Kalichman L. Deep tissue massage: What are we talking about? J Bodyw Mov Ther. 2018 Apr;22(2):247-251. doi: 10.1016/j.jbmt.2017.05.006. Epub 2017 May 17. — View Citation

Le Huec JC, Thompson W, Mohsinaly Y, Barrey C, Faundez A. Sagittal balance of the spine. Eur Spine J. 2019 Sep;28(9):1889-1905. doi: 10.1007/s00586-019-06083-1. Epub 2019 Jul 22. Erratum In: Eur Spine J. 2019 Aug 26;: — View Citation

Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017 Feb 18;389(10070):736-747. doi: 10.1016/S0140-6736(16)30970-9. Epub 2016 Oct 11. — View Citation

Majchrzycki M, Kocur P, Kotwicki T. Deep tissue massage and nonsteroidal anti-inflammatory drugs for low back pain: a prospective randomized trial. ScientificWorldJournal. 2014 Feb 23;2014:287597. doi: 10.1155/2014/287597. eCollection 2014. — View Citation

Marshall PWM, Schabrun S, Knox MF. Physical activity and the mediating effect of fear, depression, anxiety, and catastrophizing on pain related disability in people with chronic low back pain. PLoS One. 2017 Jul 7;12(7):e0180788. doi: 10.1371/journal.pone.0180788. eCollection 2017. — View Citation

Nakipoglu GF, Karagoz A, Ozgirgin N. The biomechanics of the lumbosacral region in acute and chronic low back pain patients. Pain Physician. 2008 Jul-Aug;11(4):505-11. — View Citation

Romanowski MW, Spiritovic M, Rutkowski R, Dudek A, Samborski W, Straburzynska-Lupa A. Comparison of Deep Tissue Massage and Therapeutic Massage for Lower Back Pain, Disease Activity, and Functional Capacity of Ankylosing Spondylitis Patients: A Randomized — View Citation

Saper RB, Lemaster C, Delitto A, Sherman KJ, Herman PM, Sadikova E, Stevans J, Keosaian JE, Cerrada CJ, Femia AL, Roseen EJ, Gardiner P, Gergen Barnett K, Faulkner C, Weinberg J. Yoga, Physical Therapy, or Education for Chronic Low Back Pain: A Randomized Noninferiority Trial. Ann Intern Med. 2017 Jul 18;167(2):85-94. doi: 10.7326/M16-2579. Epub 2017 Jun 20. — View Citation

Schuenke MD, Vleeming A, Van Hoof T, Willard FH. A description of the lumbar interfascial triangle and its relation with the lateral raphe: anatomical constituents of load transfer through the lateral margin of the thoracolumbar fascia. J Anat. 2012 Dec;221(6):568-76. doi: 10.1111/j.1469-7580.2012.01517.x. Epub 2012 May 15. — View Citation

Seffrin CB, Cattano NM, Reed MA, Gardiner-Shires AM. Instrument-Assisted Soft Tissue Mobilization: A Systematic Review and Effect-Size Analysis. J Athl Train. 2019 Jul;54(7):808-821. doi: 10.4085/1062-6050-481-17. Epub 2019 Jul 19. — View Citation

Tesarz J, Hoheisel U, Wiedenhofer B, Mense S. Sensory innervation of the thoracolumbar fascia in rats and humans. Neuroscience. 2011 Oct 27;194:302-8. doi: 10.1016/j.neuroscience.2011.07.066. Epub 2011 Aug 2. — View Citation

van den Dolder PA, Ferreira PH, Refshauge KM. Effectiveness of Soft Tissue Massage for Nonspecific Shoulder Pain: Randomized Controlled Trial. Phys Ther. 2015 Nov;95(11):1467-77. doi: 10.2522/ptj.20140350. Epub 2015 May 28. — View Citation

van den Dolder PA, Roberts DL. A trial into the effectiveness of soft tissue massage in the treatment of shoulder pain. Aust J Physiother. 2003;49(3):183-8. doi: 10.1016/s0004-9514(14)60238-5. — View Citation

Willard FH, Vleeming A, Schuenke MD, Danneels L, Schleip R. The thoracolumbar fascia: anatomy, function and clinical considerations. J Anat. 2012 Dec;221(6):507-36. doi: 10.1111/j.1469-7580.2012.01511.x. Epub 2012 May 27. — View Citation

Williams ACC, Craig KD. Updating the definition of pain. Pain. 2016 Nov;157(11):2420-2423. doi: 10.1097/j.pain.0000000000000613. No abstract available. — View Citation

Zheng Z, Wang J, Gao Q, Hou J, Ma L, Jiang C, Chen G. Therapeutic evaluation of lumbar tender point deep massage for chronic non-specific low back pain. J Tradit Chin Med. 2012 Dec;32(4):534-7. doi: 10.1016/s0254-6272(13)60066-7. — View Citation

* Note: There are 23 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Lumbar anterior flexion (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar anterior flexion (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Lumbar posterior flexion (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar posterior flexion (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Lumbar right flexion (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar right flexion (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Lumbar left flexion (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar left flexion (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Lumbar right rotation (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar right rotation (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Lumbar left rotation (PRE) Electrogoniometric measurement of the angular range of motion the day before the therapy Through study completion, an average of 2 weeks.
Primary Lumbar left rotation (POST) Electrogoniometric measurement of the angular range of motion the day after the therapy Through study completion, an average of 2 weeks.
Primary Stiffness (S) of the right longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the intervention Through study completion, an average of 2 weeks.
Primary Stiffness (S) of the right longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Stiffness (S) of the left longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the therapy Through study completion, an average of 2 weeks.
Primary Stiffness (S) of the left longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Elasticity (D) of the right longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the therapy Through study completion, an average of 2 weeks.
Primary Elasticity (D) of the right longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Elasticity (D) of the left longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the therapy Through study completion, an average of 2 weeks.
Primary Elasticity (D) of the left longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Muscle tone (F) of the right longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the therapy Through study completion, an average of 2 weeks.
Primary Muscle tone (F) of the right longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Muscle tone (F) of the left longissimus muscle (PRE) Myotonometer examination of soft tissue properties the day before the therapy Through study completion, an average of 2 weeks.
Primary Muscle tone (F) of the left longissimus muscle (POST) Myotonometer examination of soft tissue properties the day after the therapy Through study completion, an average of 2 weeks.
Primary Pressure pain threshold (PPT) of the right longissimus muscle (PRE) Examination of the first discomfort threshold using an algometer the day before the therapy Through study completion, an average of 2 weeks.
Primary Pressure pain threshold (PPT) of the right longissimus muscle (POST) Examination of the first discomfort threshold using an algometer the day after the therapy Through study completion, an average of 2 weeks.
Primary Pressure pain threshold (PPT) of the left longissimus muscle (PRE) Examination of the first discomfort threshold using an algometer the day before the therapy Through study completion, an average of 2 weeks.
Primary Pressure pain threshold (PPT) of the left longissimus muscle (POST) Examination of the first discomfort threshold using an algometer the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right longissimus muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the right longissimus muscle the day before therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right longissimus muscle (POST) Electromyographic measurements of maximal voluntary contraction of the right longissimus muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left longissimus muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the left longissimus muscle the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left longissimus muscle (POST) Electromyographic measurements of maximal voluntary contraction of the left longissimus muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right iliocostalis muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the left longissimus muscle the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right iliocostalis muscle (POST) Electromyographic measurements of maximal voluntary contraction of the right iliocostalis muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left iliocostalis muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the left longissimus muscle the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left iliocostalis muscle (POST) Electromyographic measurements of maximal voluntary contraction of the left longissimus muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right multifidus muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the right multifidus muscle the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for right multifidus muscle (POST) Electromyographic measurements of maximal voluntary contraction of the right multifidus muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left multifidus muscle (PRE) Electromyographic measurements of maximal voluntary contraction of the left multifidus muscle the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - MVC for left multifidus muscle (POST) Electromyographic measurements of maximal voluntary contraction of the left multifidus muscle the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right longissimus muscle (PRE) Electromyographic measurements of the right longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right longissimus muscle (POST) Electromyographic measurements of the right longissimus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left longissimus muscle (PRE) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left longissimus muscle (POST) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right iliocostalis muscle (PRE) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right iliocostalis muscle (POST) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left iliocostalis muscle (PRE) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left iliocostalis muscle (POST) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right multifidus muscle (PRE) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for right multifidus muscle (POST) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left multifidus muscle (PRE) Electromyographic measurements of the left longissimus muscle during the Flexion-Relaxation test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - FR test for left multifidus muscle (POST) Electromyographic measurements of the left multifidus muscle during the Flexion-Relaxation test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right longissimus muscle (PRE) Electromyographic measurements of the left multifidus muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right longissimus muscle (POST) Electromyographic measurements of the right longissimus muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left longissimus muscle (PRE) Electromyographic measurements of the left longissimus muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left longissimus muscle (POST) Electromyographic measurements of the left longissimus muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right iliocostalis muscle (PRE) Electromyographic measurements of the right iliocostalis muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right iliocostalis muscle (POST) Electromyographic measurements of the right iliocostalis muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left iliocostalis muscle (PRE) Electromyographic measurements of the left iliocostalis muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left iliocostalis muscle (POST) Electromyographic measurements of the left iliocostalis muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right multifidus muscle (PRE) Electromyographic measurements of the right multifidus muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for right multifidus muscle (POST) Electromyographic measurements of the right multifidus muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left multifidus muscle (PRE) Electromyographic measurements of the left multifidus muscle during sitting and standing test the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - sitting and standing test for left multifidus muscle (POST) Electromyographic measurements of the left multifidus muscle during sitting and standing test the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right longissimus muscle (PRE) Electromyographic measurements of the right longissimus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right longissimus muscle (POST) Electromyographic measurements of the right longissimus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left longissimus muscle (PRE) Electromyographic measurements of the left longissimus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left longissimus muscle (POST) Electromyographic measurements of the left longissimus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right iliocostalis muscle (PRE) Electromyographic measurements of the right iliocostalis muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right iliocostalis muscle (POST) Electromyographic measurements of the right iliocostalis muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left iliocostalis muscle (PRE) Electromyographic measurements of the left iliocostalis muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left iliocostalis muscle (POST) Electromyographic measurements of the left iliocostalis muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right multifidus muscle (PRE) Electromyographic measurements of the right multifidus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for right multifidus muscle (POST) Electromyographic measurements of the right multifidus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left multifidus muscle (PRE) Electromyographic measurements of the left multifidus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (1 kg) for left multifidus muscle (POST) Electromyographic measurements of the left multifidus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right longissimus muscle (PRE) Electromyographic measurements of the right longissimus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right longissimus muscle (POST) Electromyographic measurements of the right longissimus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left longissimus muscle (PRE) Electromyographic measurements of the left longissimus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left longissimus muscle (POST) Electromyographic measurements of the left longissimus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right iliocostalis muscle (PRE) Electromyographic measurements of the right iliocostalis muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right iliocostalis muscle (POST) Electromyographic measurements of the right iliocostalis muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left iliocostalis muscle (PRE) Electromyographic measurements of the left iliocostalis muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left iliocostalis muscle (POST) Electromyographic measurements of the left iliocostalis muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right multifidus muscle (PRE) Electromyographic measurements of the right multifidus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for right multifidus muscle (POST) Electromyographic measurements of the right multifidus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left multifidus muscle (PRE) Electromyographic measurements of the left multifidus muscle during the weight holding test (1kg) the day before the therapy Through study completion, an average of 2 weeks.
Primary EMG - weight holding test (2 kg) for left multifidus muscle (POST) Electromyographic measurements of the left multifidus muscle during the weight holding test (1kg) the day after the therapy Through study completion, an average of 2 weeks.
Primary Revised Oswestry Pain Questionnaire (PRE) Revised Oswestry Pain Questionnaire (ODI) - the day before therapy. The minimum score is 0, while the maximum is 50, which proves 100% disability. A higher result is worse and proves the patient's disability in everyday activities. Through study completion, an average of 2 weeks.
Primary Revised Oswestry Pain Questionnaire (POST) Revised Oswestry Pain Questionnaire (ODI) - the day after therapy. The minimum score is 0, while the maximum is 50, which proves 100% disability. A higher result is worse and proves the patient's disability in everyday activities. Through study completion, an average of 2 weeks.
Primary Roland-Morris Disability Questionnaire (PRE) Roland-Morris Disability Questionnaire (RMDQ) - the day before therapy. The minimum score is 0, while the maximum is 24. The higher the score, the worse it is and it illustrates the poor functional condition of the examined person. Through study completion, an average of 2 weeks.
Primary Roland-Morris Disability Questionnaire (POST) Roland-Morris Disability Questionnaire (RMDQ) - the day after therapy. The minimum score is 0, while the maximum is 24. The higher the score, the worse it is and it illustrates the poor functional condition of the examined person. Through study completion, an average of 2 weeks.
Primary Visual-Analog Scale (PRE) Visual-Analog Scale (VAS) - the day before therapy. The minimum score is 0 and the maximum score is 10. The higher the score, the worse it is and it reflects the subjective level of pain experienced. Through study completion, an average of 2 weeks.
Primary Visual-Analog Scale (POST) Visual-Analog Scale (VAS) - the day after therapy. The minimum score is 0 and the maximum score is 10. The higher the score, the worse it is and it reflects the subjective level of pain experienced. Through study completion, an average of 2 weeks.
See also
  Status Clinical Trial Phase
Recruiting NCT05963451 - Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
Completed NCT04283370 - A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain N/A
Completed NCT04824547 - Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals N/A
Completed NCT04046419 - In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
Completed NCT04399772 - COgNitive FuncTional Therapy+ for Chronic Low Back paIn N/A
Recruiting NCT05780021 - Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation N/A
Completed NCT04555278 - Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain N/A
Completed NCT04530071 - Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain Phase 1/Phase 2
Not yet recruiting NCT06347328 - The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain N/A
Not yet recruiting NCT04940715 - Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain N/A
Recruiting NCT04683718 - A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management N/A
Recruiting NCT05724160 - Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain N/A
Recruiting NCT06030128 - Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults N/A
Recruiting NCT05846087 - Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia N/A
Active, not recruiting NCT05396014 - The BEST Trial: Biomarkers for Evaluating Spine Treatments Phase 4
Active, not recruiting NCT06140862 - Ankle Spine Syndrome "RAFFET Syndrome II N/A
Completed NCT05512338 - Motivation and Adherence to Exercise Recommendations N/A
Recruiting NCT05021146 - Essential Oil for Chronic Low Back Pain N/A
Recruiting NCT05120921 - Osteopathic Single CAse Research for Patients With Chronic Low Back Pain N/A
Completed NCT05050695 - Correlation Between Posterior Oblique Sling Activation and Contralateral Glenohumeral Stability in Low Back Pain